Henry Schein expands supplies platform with Acentus 

MELVILLE, N.Y. - Henry Schein has signed an agreement to buy Tampa, Fla.-based Acentus, a national supplier specializing in delivering continuous glucose monitors (CGMs) with $35 million in annual revenue. 

Along with its previous acquisitions of Prism Medical Products in 2021 and Shield Healthcare and Mini Pharmacy in 2023, Henry Schein now expects its home medical supply platform to have annual revenue of about $350 million. 

“As the delivery of health care in the U.S. is increasingly provided in home-based settings, Henry Schein is strategically expanding our offerings to meet the growing demand,” said Stanley M. Bergman, chairman of the board and CEO, Henry Schein. “With Acentus, we will strengthen our position nationally in the home medical supply market and better serve our valued customers, including clinics, physician practices, health systems, ambulatory surgery centers, and most importantly, patients and families.” 

Provident Healthcare Partners acted as the exclusive financial advisor to Acentus. 

Upon closing, Acentus founders Brett Carroll, Todd Cianfrocca, Greg Duvall and Julio Valdivia will join Henry Schein and bring their expertise and experience in the product category and the health care industry. 

“We are delighted to partner with Henry Schein and further our efforts to provide accessible disposable medical supplies to the thousands of individuals nationwide who rely on these products to manage their chronic conditions,” said Cianfrocca, CEO of Acentus. “We are excited to contribute to the growth of Henry Schein’s emerging home health care business.” 

With approximately 26,000 team members worldwide, Henry Schein’s network of trusted advisors provides more than 1 million customers globally with more than 300 valued solutions that help improve operational success and clinical outcomes.   

Analysis: 

• Henry Schein’s acquisition of Acentus is only the most recent example of accelerated M&A activity in the diabetes and CGM market. Cardinal Health also announced in November that it was buying Advanced Diabetes Supply Group for $1.1 billion. 
• Additionally, other companies, like AdaptHealth, are trying to ramp up their businesses in the market.